EPE176 | The positive impact of multi-month dispensing (MMD) of ARVs on client treatment continuity | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
EPE177 | Providers' perspectives on barriers and facilitators for implementation of differentiated service delivery models for HIV treatment in Beira City, Mozambique | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
EPE178 | The impact of decentralized 'out-of-facility individual delivery models' in improving retention and viral suppression of people living with HIV in northeast India | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
EPE179 | Viral load outcomes and factors associated with viral suppression among HIV-positive patients receiving multi-month dispensing of antiretroviral drugs in the context of COVID-19 pandemic: experience from 7 states in Nigeria | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
EPE180 | The use of vending machines for dispensing of HIV self-testing kits in Gauteng, South Africa: a pilot study | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
EPE181 | Leaving no one behind: The impact of kindergarten ART clinic on HIV treatment outcomes among children enrolled in kindergarten HIV program at Lighthouse HIV care facilities | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
OAE0102 | Medical drones to support HIV differentiated service delivery in an island population in Uganda | Oral abstract session with live Q&A | Differentiated service delivery for HIV testing, prevention and treatment |
OAE0104 | How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? | Oral abstract session with live Q&A | Differentiated service delivery for HIV testing, prevention and treatment |
OAE0105 | The effect of six-month PrEP dispensing supported with interim HIV self-testing on PrEP continuation at 12 months in Kenya: a randomized implementation trial | Oral abstract session with live Q&A | Differentiated service delivery for HIV testing, prevention and treatment |
PESUE19 | What are the 12-month retention and viral suppression outcomes for South African ART clients enrolled in DSD models compared to conventional care? | Poster exhibition | Differentiated service delivery for HIV testing, prevention and treatment |